What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.   Read More

What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.   Read More

On a day when the market is in full-tilt rally mode on the GDP number, shares of Dow component Merck and the company it's buying, Schering-Plough, are sliding. So, what gives?    Read More

With Amgen dropping after hours and Merck, Celgene and others reporting earnings on Thursday, how should you game health care?   Read More

The folks at Eli Lilly probably cringe every time I go here, but the company this morning reported that third quarter U.S. sales of the erectile dysfunction drug Cialis sprung 13 percent to nearly $159 million.    Read More

In today's trading session, a total of 63 stocks in the S&P 500 hit new 52-week highs.  Here is a look at those companies.   Read More

In today's trading session, a total of 99 stocks in the S&P 500 reached new 52-week highs.  Here is a look at those companies.   Read More

Following a strong day for new 52-week highs on Thursday, with a total of 71 S&P companies reaching this level, U.S. stocks are showing modest gains in early trading. Here is a look at today's new 52-week highs.   Read More

Following a strong day for new 52-week highs on Thursday, with a total of 71 S&P companies reaching this level, U.S. stocks are showing modest gains in early trading. Here is a look at today's new 52-week highs.   Read More

The drug biz is abuzz over social media. It's the new frontier. For a lot of PR and corporate communications teams it's all about new media and social media. Some biopharmas, big and small, now have directors of social media. Most are still trying to find their way, but the Food and Drug Administration may soon direct them.    Read More